- Filed
- Mar 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 28, 2025 | 63.59M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $62.84M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $48.29M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $209.69M |
| Current Assets | FY 2024 · Dec 31, 2023 | $112.42M |
| Total Assets | FY 2024 · Dec 31, 2023 | $189M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 56.07M sh |
| Capex | FY 2024 · Dec 31, 2022 | $1.62M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$84.91M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$1.33 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$1.33 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $141.84M |
| Net Income | FY 2024 · Dec 31, 2022 | −$74.41M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$65.33M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $89.77M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2022 | $58.84M |
| Revenue | FY 2024 · Dec 31, 2022 | $148.62M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $81.88M |